- Intestinal ultrasound for intestinal Behçet disease reflects endoscopic activity and histopathological findings
-
Yaguchi K, Kunisaki R, Sato S, Hirai K, Izumi M, Fukuno Y, Tanaka M, Okazaki M, Wu R, Nishikawa Y, Matsune Y, Shibui S, Nakamori Y, Nishio M, Matsubayashi M, Ogashiwa T, Fujii A, Toritani K, Kimura H, Kumagai E, Sasahara Y, Inayama Y, Fujii S, Ebina T, Numata K, Maeda S
- KMID: 2558190
- Intest Res.
- 2024 Jul;22(3):297-309.
- doi: 10.5217/ir.2023.00129
Background/Aims: Intestinal Behçet disease is typically associated with ileocecal punched-out ulcers and significant morbidity and mortality. Intestinal ultrasound is a noninvasive imaging technique for disease monitoring. However, no previous reports... -
- CITED
-
- Close
- SHARE
-
- Close
- Halitosis: an underestimated but important extraintestinal manifestation in inflammatory bowel disease
-
Qian XX
- KMID: 2558198
- Intest Res.
- 2024 Jul;22(3):387-388.
- doi: 10.5217/ir.2024.00016
-
- CITED
-
- Close
- SHARE
-
- Close
- Live-attenuated vaccination in patients with inflammatory bowel disease while continuing or after elective switch to vedolizumab
-
Shiga H, Nagai H, Shimoyama Y, Naito T, Moroi R, Kakuta Y, Kinouchi Y, Masamune A
- KMID: 2558197
- Intest Res.
- 2024 Jul;22(3):378-386.
- doi: 10.5217/ir.2023.00203
Background/Aims: Vedolizumab (VDZ) is a gut-selective agent with a favorable safety profile. We aimed to assess the feasibility of elective switch from other advanced therapies to VDZ and subsequent live-attenuated... -
- CITED
-
- Close
- SHARE
-
- Close
- Ustekinumab for anti-tumor necrosis factor refractory pediatric ulcerative colitis: a promising approach towards endoscopic healing
-
Rehman R, Riaz MS, Esharif D, Has P, Herzlinger M, Shapiro J, Subedi S
- KMID: 2558194
- Intest Res.
- 2024 Jul;22(3):351-356.
- doi: 10.5217/ir.2023.00091
Background/Aims: To describe the role of ustekinumab in inducing remission and endoscopic healing in anti-tumor necrosis factor α nonresponsive pediatric ulcerative colitis patients at a tertiary care inflammatory bowel disease... -
- CITED
-
- Close
- SHARE
-
- Close
- Diagnostic strategy of irritable bowel syndrome: a low- and middle-income country perspective
-
Hidayat AA, Waskito LA, Sugihartono T, Aftab H, Rezkitha YAA, Vilaichone Rk, Miftahussurur M
- KMID: 2558189
- Intest Res.
- 2024 Jul;22(3):286-296.
- doi: 10.5217/ir.2023.00199
Irritable bowel syndrome (IBS) is a highly prevalent gastrointestinal disorder associated with substantial impairment which considerably burdens healthcare systems worldwide. Research on IBS has largely been conducted in high-income countries... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term efficacy and safety of tofacitinib in patients with ulcerative colitis: 3-year results from a real-world study
-
Shimizu H, Aonuma Y, Hibiya S, Kawamoto A, Takenaka K, Fujii T, Saito E, Nagahori M, Ohtsuka K, Okamoto R
- KMID: 2558196
- Intest Res.
- 2024 Jul;22(3):369-377.
- doi: 10.5217/ir.2023.00194
Background/Aims: The efficacy and safety of tofacitinib for the treatment of refractory ulcerative colitis (UC) has been demonstrated in clinical trials. Although, a series of reports with real-world evidence of... -
- CITED
-
- Close
- SHARE
-
- Close
- Adequacy of sigmoidoscopy as compared to colonoscopy for assessment of disease activity in patients of ulcerative colitis: a prospective study
-
Patel ST, Jena A, Chandnani S, Jain S, Nawghare P, Bansal S, Gandhi H, Malokar R, Chudasama J, Debnath P, Kahmei S, Kamat R, Kini S, Contractor QQ, Rathi PM
- KMID: 2558191
- Intest Res.
- 2024 Jul;22(3):310-318.
- doi: 10.5217/ir.2023.00174
Background/Aims: Patients of ulcerative colitis (UC) on follow-up are routinely evaluated by sigmoidoscopy. There is no prospective literature to support this practice. We assessed agreement between sigmoidoscopy and colonoscopy prospectively... -
- CITED
-
- Close
- SHARE
-
- Close
- Association between oral corticosteroid starting dose and the incidence of pneumonia in Japanese patients with ulcerative colitis: a nation-wide claims database study
-
Matsuoka K, Inoue T, Tsuchiya H, Nagano K, Iwahori T
- KMID: 2558192
- Intest Res.
- 2024 Jul;22(3):319-335.
- doi: 10.5217/ir.2023.00071
Background/Aims: A previous study demonstrated that half of patients started oral corticosteroids (OCS) for ulcerative colitis (UC) exacerbations at lower doses than recommended by Japanese treatment guidelines (initial OCS prednisolone... -
- CITED
-
- Close
- SHARE
-
- Close
- Changes in the clinical course and prognosis of ulcerative colitis in Chinese populations: a retrospective cohort study
-
Liu X, Yang Q, Diao N, Tang J, Huang Z, Gao X, Chao K
- KMID: 2558195
- Intest Res.
- 2024 Jul;22(3):357-368.
- doi: 10.5217/ir.2023.00106
Background/Aims: Data on the natural course of Chinese patients with ulcerative colitis (UC) was lacking. This study aimed to evaluate the natural history and prognosis of patients with UC in... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of COVID-19 vaccines on patient-reported outcomes in patients with inflammatory bowel disease: a multicenter survey study in Korea
-
Ji JH, Shin SH, Park YE, Park J, Park JJ, Cheon JH, Kim TI, Kang SB, Park SH, Park SJ, IBD Research Group of the Korean Association for the Study of Intestinal Diseases (KASID)
- KMID: 2558193
- Intest Res.
- 2024 Jul;22(3):336-350.
- doi: 10.5217/ir.2023.00077
Background/Aims: The impact of vaccination on inflammatory bowel disease (IBD) patients is still unknown, and no studies have assessed the changes in patient-reported outcomes (PROs) after vaccination in patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023
-
Yen HH, Wu JF, Wang HY, Chang TA, Chang CH, Chang CW, Chao TH, Chou JW, Chou YH, Chuang CH, Hsu WH, Hsu TC, Huang TY, Hung TI, Le PH, Lin CC, Lin CC, Lin CP, Lin JK, Lin WC, Ni YH, Shieh MJ, Shih IL, Shun CT, Tsai TJ, Wang CY, Weng MT, Wong JM, Wu DC, Wei SC
- KMID: 2558187
- Intest Res.
- 2024 Jul;22(3):213-249.
- doi: 10.5217/ir.2023.00050
Ulcerative colitis (UC) is a chronic inflammation of the gastrointestinal tract and is characterized by alternating periods of inflammation and remission. Although UC incidence is lower in Taiwan than in... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of Crohn’s disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023
-
Wu JF, Yen HH, Wang HY, Chang TA, Chang CH, Chang CW, Chao TH, Chou JW, Chou YH, Chuang CH, Hsu WH, Hsu TC, Huang TY, Hung TI, Le PH, Lin CC, Lin CC, Lin CP, Lin JK, Lin WC, Ni YH, Shieh MJ, Shih IL, Shun CT, Tsai TJ, Wang CY, Weng MT, Wong JM, Wu DC, Wei SC
- KMID: 2558188
- Intest Res.
- 2024 Jul;22(3):250-285.
- doi: 10.5217/ir.2024.00060
Crohn’s disease (CD) is a chronic, fluctuating inflammatory condition that primarily affects the gastrointestinal tract. Although the incidence of CD in Taiwan is lower than that in Western countries, the... -
- CITED
-
- Close
- SHARE
-
- Close
